Massachusetts General Hospital Logo

Neuroendocrine and Pituitary
Tumor Clinical Center (NEPTCC) Bulletin

Winter 2017/2018 | Volume 24, Issue 1

Research Studies Available

Patients may qualify for research studies in the Neuroendocrine and Pituitary Tumor Clinical Center.  We are currently accepting the following categories of patients for screening to determine study eligibility.  Depending on the study, subjects may receive free testing, medication and/or stipends.

 

SUBJECTS STUDIES CONTACT
617-726-3870
Adults with active or treated acromegaly •Quality of life
•Cross-sectional bone density study
•Study evaluating sustained control with oral octreotide
Lisa Nachtigall, MD
Karen Pulaski Liebert, RN
Men with hypopituitarism •Characterization of oxytocin deficiency Elizabeth Lawson, MD

 

The Neuroendocrine and Pituitary Tumor Clinical Center is involved in many different research studies.
Types of studies and enrollment status changes frequently, so please call our
office (617-726-3870) or check our webpage (massgeneral.org/neuroendocrine) for more
information about potential studies which may not be listed here.